<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01259570</url>
  </required_header>
  <id_info>
    <org_study_id>3000007066</org_study_id>
    <nct_id>NCT01259570</nct_id>
  </id_info>
  <brief_title>Bioavailability of Vitamin D Encapsulated in Casein Micelles, Compared to Its Bioavailability in the Milk-fat, or in a Synthetic Emulsifier Currently Used for Supplementation and Enrichment</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Technion, Israel Institute of Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The encapsulation within CM may improve bioavailability (BA) of vitamin D (VD), even in
      absence of fat.

      As a model the investigators have chosen nonfat yoghurt. The investigators will prepare
      yoghurts from 4 milks: (1) Skimmilk enriched with 50,000 IU/150gr VD encapsulated in CM2 ;
      (2) 3% fat milk wherein same dose of VD - dissolved in milk fat and homogenized into
      skimmilk; (3) 3% fat milk wherein VD, at same dose, will be in CM; (4) Placebo: unenriched
      skimmilk. 120 healthy adults aged 18-65 will randomized to 5 groups and receive 150 gr
      yoghurt. Blood will be drawn before ingestion and on days 1,7,14. 25(OH)D will be det. by
      CMIA. In vitro simulated digestion will be studied.

      Expected results: The BA of VD in CM would not be lower than in fat
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2011</start_date>
  <completion_date type="Anticipated">May 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bioavailability of vitamin D encapsulated in casein micelles, compared to its bioavailability in the milk-fat.</measure>
    <time_frame>1 year</time_frame>
    <description>As a model we have chosen nonfat yoghurt. We will prepare yoghurts from 4 milks: (1) Skimmilk enriched with 50,000 IU/150gr VD encapsulated in CM2 ; (2) 3% fat milk wherein same dose of VD - dissolved in milk fat and homogenized into skimmilk; (3) 3% fat milk wherein VD, at same dose, will be in CM; (4) Placebo: unenriched skimmilk. 120 healthy adults aged 18-65 will randomized to 5 groups and receive 150 gr yoghurt. Blood will be drawn before ingestion and on days 1,7,14. 25(OH)D will be det. by</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Healthy Individuals</condition>
  <arm_group>
    <arm_group_label>Skimmilk enriched with VD encapsulated in CM</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>VD will be dissolved in milkfat and homogenized into skimmilk</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>VD will be dissolved in milkfat and homogenized into skimmilk</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3% fat milk wherein the VD will be in CM</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3% fat milk wherein the VD will be in CM</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo: un-enriched skimmilk.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Placebo: un-enriched skimmilk.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Group 1</intervention_name>
    <description>Skimmilk enriched with VD encapsulated in CM</description>
    <arm_group_label>Skimmilk enriched with VD encapsulated in CM</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Group 2</intervention_name>
    <description>VD will be dissolved in milkfat and homogenized into skimmilk</description>
    <arm_group_label>VD will be dissolved in milkfat and homogenized into skimmilk</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>group 3</intervention_name>
    <description>3% fat milk wherein the VD will be in CM</description>
    <arm_group_label>3% fat milk wherein the VD will be in CM</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Group 4</intervention_name>
    <description>Placebo: un-enriched skimmilk.</description>
    <arm_group_label>Placebo: un-enriched skimmilk.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers

        Exclusion Criteria:

          -  Metabolic disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>December 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2010</study_first_submitted>
  <study_first_submitted_qc>December 13, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2010</study_first_posted>
  <last_update_submitted>December 13, 2010</last_update_submitted>
  <last_update_submitted_qc>December 13, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 14, 2010</last_update_posted>
  <responsible_party>
    <name_title>Sophia Ish-Shalom</name_title>
    <organization>Rambam Health Care Campus</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

